IN2014DN08610A - - Google Patents

Info

Publication number
IN2014DN08610A
IN2014DN08610A IN8610DEN2014A IN2014DN08610A IN 2014DN08610 A IN2014DN08610 A IN 2014DN08610A IN 8610DEN2014 A IN8610DEN2014 A IN 8610DEN2014A IN 2014DN08610 A IN2014DN08610 A IN 2014DN08610A
Authority
IN
India
Prior art keywords
mammary gland
gland
peptides
cessation
pharmaceutical composition
Prior art date
Application number
Other languages
English (en)
Inventor
Jose Mario Iscovich
Javier Iscovich
Original Assignee
Mileutis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mileutis Ltd filed Critical Mileutis Ltd
Publication of IN2014DN08610A publication Critical patent/IN2014DN08610A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IN8610DEN2014 2012-03-19 2013-03-08 IN2014DN08610A (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261612410P 2012-03-19 2012-03-19
PCT/IL2013/050214 WO2013140388A1 (en) 2012-03-19 2013-03-08 Peptides for management of lactation

Publications (1)

Publication Number Publication Date
IN2014DN08610A true IN2014DN08610A (enExample) 2015-05-22

Family

ID=49221927

Family Applications (1)

Application Number Title Priority Date Filing Date
IN8610DEN2014 IN2014DN08610A (enExample) 2012-03-19 2013-03-08

Country Status (11)

Country Link
US (1) US9487557B2 (enExample)
EP (1) EP2828281B1 (enExample)
JP (1) JP6426599B2 (enExample)
CN (1) CN104321336B (enExample)
AU (1) AU2013236975B2 (enExample)
BR (1) BR112014023087A8 (enExample)
CA (1) CA2867557C (enExample)
ES (1) ES2759980T3 (enExample)
IL (1) IL234574B (enExample)
IN (1) IN2014DN08610A (enExample)
WO (1) WO2013140388A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102022118B1 (ko) * 2019-01-07 2019-09-18 주식회사 아스트로젠 중추신경계 질환의 예방 또는 치료용 세린 유도체 화합물
CN111632128B (zh) * 2019-02-14 2022-07-05 三凡生技研发股份有限公司 短链胜肽组合物在预防或治疗干眼症的应用
BR112022010385A2 (pt) 2019-11-28 2022-08-23 Boehringer Ingelheim Vetmedica Gmbh Uso de inibidores de sglt-2 na secagem de mamíferos não humanos
EP4329790A1 (en) * 2021-04-28 2024-03-06 Mileutis Ltd. Compositions and methods for modulating mammary disorders and conditions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391849B1 (en) 1999-11-19 2002-05-21 Agricultural Research Organization, The Volcani Center Method and pharmaceutical composition for disrupting lactation in a mammary gland and for treating and preventing mastitis
JPWO2002072629A1 (ja) * 2001-03-09 2004-07-02 明治製菓株式会社 免疫増強剤
ZA200710374B (en) * 2005-05-02 2009-06-24 Mileutis Ltd Pharmaceutical compositions comprising casein derived peptides and methods of use thereof
UY29515A1 (es) * 2005-05-02 2007-11-30 Mileutis Ltd Composiciones farmaceuticas que constan de peptidos derivados de la caseina y métodos del uso de los mismos
CA2695374A1 (en) * 2007-08-15 2009-02-19 Amunix, Inc. Compositions and methods for modifying properties of biologically active polypeptides

Also Published As

Publication number Publication date
ES2759980T3 (es) 2020-05-12
AU2013236975A1 (en) 2014-10-23
US9487557B2 (en) 2016-11-08
JP6426599B2 (ja) 2018-11-21
CN104321336A (zh) 2015-01-28
EP2828281B1 (en) 2019-09-18
WO2013140388A1 (en) 2013-09-26
JP2015516377A (ja) 2015-06-11
CA2867557A1 (en) 2013-09-26
US20150093400A1 (en) 2015-04-02
EP2828281A1 (en) 2015-01-28
CA2867557C (en) 2020-03-10
EP2828281A4 (en) 2015-11-11
BR112014023087A8 (pt) 2018-01-16
AU2013236975B2 (en) 2017-10-19
BR112014023087A2 (pt) 2017-06-20
CN104321336B (zh) 2021-08-06
IL234574B (en) 2020-09-30

Similar Documents

Publication Publication Date Title
MX2019009132A (es) Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
PH12016501512A1 (en) Treatment for resistant acne
EP4620519A3 (en) Methods and compositions relating to chondrisomes from blood products
NI201500024A (es) Anticuerpos y vacunas para utilizarse en el tratamiento de cánceres por ror1 y para inhibir la metástasis.
SG10201903119QA (en) Polypeptide vaccine
GB2541571A (en) Pharmaceutical compositions
IN2014DN10670A (enExample)
MX2015006681A (es) Formulaciones de vancomicina estabilizadas.
NZ730763A (en) Methods of treating a tauopathy
MY168032A (en) Warm-Cool Beauty Treatment Device
MX377729B (es) Métodos para tratamiento del melanoma.
PH12015501983B1 (en) Peptides and compositions for treatment of joint damage
MX340446B (es) Metodos para tratar y prevenir infecciones por estafilococo dorado y condiciones asociadas.
EP4414376A3 (en) Novel depsipeptide and uses thereof
MX349948B (es) Proteínas inmunógenas y composiciones para el tratamiento y prevención de streptococcus agalactiae.
GB201118201D0 (en) Novel peptides
MX356755B (es) Compuestos de tipo fumagilol y metodos para su elaboración y uso.
EA201692554A1 (ru) Менингококковые вакцины
MY191539A (en) Streptococcal vaccine
MX2016007626A (es) Peptido antimicrobiano y usos del mismo.
NZ708595A (en) Compositions comprising vortioxetine and donepezil
MX364528B (es) Witanólidos útiles para el tratamiento de enfermedades neurodegenerativas.
TN2014000518A1 (en) Reassortant btv and ahsv vaccines
MX363631B (es) Composiciones y metodos para tratar infecciones bacterianas.
PH12019500344A1 (en) Immunotherapy for polyomaviruses